Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes 55:3418-3428, 2006
DOI: 10.2337/db06-0399
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wolins, N. E.
Right arrow Articles by Bickel, P. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wolins, N. E.
Right arrow Articles by Bickel, P. E.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

OXPAT/PAT-1 Is a PPAR-Induced Lipid Droplet Protein That Promotes Fatty Acid Utilization

Nathan E. Wolins1, Benjamin K. Quaynor1, James R. Skinner1, Anatoly Tzekov1, Michelle A. Croce2, Matthew C. Gropler2, Vijayalakshmi Varma3, Aiwei Yao-Borengasser3, Neda Rasouli3, Philip A. Kern3, Brian N. Finck2, and Perry E. Bickel1,4

1 Division of Endocrinology, Metabolism, and Lipid Research, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
2 Division of Geriatrics and Nutritional Science, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
3 Division of Endocrinology, Central Arkansas Veterans Healthcare System and University of Arkansas for Medical Sciences, Little Rock, Arkansas
4 Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri

Address correspondence and reprint requests to Perry E. Bickel, Departments of Medicine and of Cell Biology and Physiology, 660 S. Euclid Ave., Campus Box 8127, St. Louis, MO 63110. E-mail: pbickel{at}im.wustl.edu

Abbreviations: Acadm, medium-chain acyl-CoA dehydrogenase; Acadv1, very-long-chain acyl-CoA dehydrogenase; BAT, brown adipose tissue; Cox4, cytochrome C oxidase 4; EST, expressed sequence tag; IBMX, 3-isobutyl-1-methylxanthine; LCFA, long-chain fatty acid; PAT, perilipin, adipophilin, and TIP47; PPAR, peroxisome proliferator–activated receptor; Sdha, subunit a of succinate dehydrogenase; STZ, streptozotocin; TAG, triacylglycerol; TZD, thiazolidinedione; WAT, white adipose tissue

Lipid droplet proteins of the PAT (perilipin, adipophilin, and TIP47) family regulate cellular neutral lipid stores. We have studied a new member of this family, PAT-1, and found that it is expressed in highly oxidative tissues. We refer to this protein as "OXPAT." Physiologic lipid loading of mouse liver by fasting enriches OXPAT in the lipid droplet tissue fraction. OXPAT resides on lipid droplets with the PAT protein adipophilin in primary cardiomyocytes. Ectopic expression of OXPAT promotes fatty acid–induced triacylglycerol accumulation, long-chain fatty acid oxidation, and mRNAs associated with oxidative metabolism. Consistent with these observations, OXPAT is induced in mouse adipose tissue, striated muscle, and liver by physiological (fasting), pathophysiological (insulin deficiency), pharmacological (peroxisome proliferator–activated receptor [PPAR] agonists), and genetic (muscle-specific PPAR{alpha} overexpression) perturbations that increase fatty acid utilization. In humans with impaired glucose tolerance, PPAR{gamma} agonist treatment induces adipose OXPAT mRNA. Further, adipose OXPAT mRNA negatively correlates with BMI in nondiabetic humans. Our collective data in cells, mice, and humans suggest that OXPAT is a marker for PPAR activation and fatty acid oxidation. OXPAT likely contributes to adaptive responses to the fatty acid burden that accompanies fasting, insulin deficiency, and overnutrition, responses that are defective in obesity and type 2 diabetes.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
D. M. Schwartz and N. E. Wolins
A simple and rapid method to assay triacylglycerol in cells and tissues
J. Lipid Res., November 1, 2007; 48(11): 2514 - 2520.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. T. Schaiff, F. F. Knapp Jr., Y. Barak, T. Biron-Shental, D. M. Nelson, and Y. Sadovsky
Ligand-Activated Peroxisome Proliferator Activated Receptor {gamma} Alters Placental Morphology and Placental Fatty Acid Uptake in Mice
Endocrinology, August 1, 2007; 148(8): 3625 - 3634.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.